EP Patent

EP0619322A2 — Prolonged delivery of peptides

Assigned to Scios LLC · Expires 1994-10-12 · 32y expired

What this patent protects

There are disclosed methods for the treatment of non-insulin dependent diabetes mellitus in a mammal comprising the prolonged administration of GLP-1(7-37), and related peptides. Also disclosed are compositions to prolong the administration of the peptides.

USPTO Abstract

There are disclosed methods for the treatment of non-insulin dependent diabetes mellitus in a mammal comprising the prolonged administration of GLP-1(7-37), and related peptides. Also disclosed are compositions to prolong the administration of the peptides.

Drugs covered by this patent

Patent Metadata

Patent number
EP0619322A2
Jurisdiction
EP
Classification
—
Expires
1994-10-12
Drug substance claim
No
Drug product claim
No
Assignee
Scios LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.